Hilleman Laboratories opens US$20m vaccine manufacturing facility in Singapore

Edb.gov.sg

10 months ago

Html
Text

Singapore among the first to test use of ammonia for fuel

Nov's SG Industry Moves: A new cGMP facility boosts vaccine and biologics development and manufacturing expertise in Singapore

Learn more

Singapore to appoint developer to launch one of the world’s first commercial project to test and deploy use of ammonia as fuel

Learn more

How Amgen and Alcon are serving biomedical needs of Southeast Asian customers from Singapore

Learn more

“Small but innovative” – ServiceNow, AvePoint on talent and partnerships they found in Singapore

Read more

Brought to you by

Singapore Economic Development Board 250 North Bridge Road #28-00 Raffles City Tower Singapore 179101

Connect with EDB :

Scan QR code to connect on WeChat

You received this email because you signed up for regular updates on Asian business insights and news.
To contact us or unsubscribe, please use the links below.

Update preferences

Unsubscribe

Share on

Other newsletters from Edb.gov.sg

EDB’s S$32m plan to drive corporate venturing Edb.gov.sg
9 days ago
Pfizer invests S$1b in Singapore to boost API manufacturing Edb.gov.sg
1 month ago
Learn why EssilorLuxottica has an R&D centre in Singapore Edb.gov.sg
2 months ago

More newsletters from Edb.gov.sg

Hilleman Laboratories opens US$20m vaccine manufacturing facility in Singapore

Share on

Other newsletters from Edb.gov.sg

Related newsletters